A Clinical Study of Cutaneous Adverse Drug Reactions

    Riddhi Shah, Sujan Narayan Agrawal, Neela Bhuptani
    Image of study
    TLDR Skin reactions to drugs are most often rashes caused by antibiotics, with nevirapine being the most common culprit; knowing these patterns can improve treatment and outcomes.
    The study conducted by Riddhi Shah, Sakshi Agrawal, and Neela Bhuptani from 2009 to 2011 involved 150 patients with adverse cutaneous drug reactions. The most common age group affected was 21-30 years (26.67%), and the male to female ratio was 0.92:1. The most common clinical type of reaction was a morbilliform rash (42.67%), and the most common group of causative agents were antimicrobials (29.33%), with nevirapine being the most common offending drug (27.33%). The mortality rate was 2% (3 out of 150 cases), all of which were cases of toxic epidermal necrolysis. The study concluded that the pattern of cutaneous adverse drug reactions and the causative drugs were notably different, and understanding these patterns and agents can aid in better management and reduced consequences, particularly in severe adverse cutaneous drug reactions.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 12 results

    Similar Research

    5 / 1000+ results
      Drug-Induced Skin, Nail, and Hair Disorders

      research Drug-Induced Skin, Nail, and Hair Disorders

      114 citations, January 2007 in “Drug Safety”
      Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.
      Cutaneous Drug Reactions

      research Cutaneous Drug Reactions

      1 citations, January 2010 in “Elsevier eBooks”
      Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.
      Dermatologic Reactions to Targeted Therapy

      research Dermatologic Reactions to Targeted Therapy

      15 citations, February 2017 in “Nursing Clinics of North America”
      Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.